2002
DOI: 10.1034/j.1398-9995.2002.02157.x
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant Hymenoptera venom allergens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
47
0
2

Year Published

2005
2005
2015
2015

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 72 publications
(49 citation statements)
references
References 40 publications
0
47
0
2
Order By: Relevance
“…For example, cross-reactivity between yellow jacket and honeybee venom hyaluronidases has been considered to be responsible for double-positive diagnosis. The ability to produce and characterize recombinant forms of venom allergens (Muller, 2002) opens the possibility for an improvement of diagnosis and for a detailed understanding of cross-reactivity patterns and specificity. This could lead to modified allergens with increased efficacy in immunotherapy treatment of allergic patients.…”
Section: Introductionmentioning
confidence: 99%
“…For example, cross-reactivity between yellow jacket and honeybee venom hyaluronidases has been considered to be responsible for double-positive diagnosis. The ability to produce and characterize recombinant forms of venom allergens (Muller, 2002) opens the possibility for an improvement of diagnosis and for a detailed understanding of cross-reactivity patterns and specificity. This could lead to modified allergens with increased efficacy in immunotherapy treatment of allergic patients.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, there is considerable interest in improving safety and efficacy of diagnostic approaches and Hymenoptera venom immunotherapy. The use of recombinant allergens for the development of component-resolved IgE immunoassays and safer and more efficacious immunotherapeutic modalities may provide such an improvement (4), but only a limited number of Hymenoptera venom allergens are available as recombinant proteins (5,6).…”
mentioning
confidence: 99%
“…The major protein allergens have been sequenced, and recombinant allergens have been described. [22][23][24] CLINICAL CONSIDERATIONS…”
Section: Hymenopteramentioning
confidence: 99%